These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12055387)

  • 41. Aberrant DNA methylation in lung cancer: biological and clinical implications.
    Zöchbauer-Müller S; Minna JD; Gazdar AF
    Oncologist; 2002; 7(5):451-7. PubMed ID: 12401908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Oncogenes and tumor suppressor genes in the pathogenesis of lung tumors].
    Wiethege T; Voss B; Müller KM
    Pathologe; 1994 Dec; 15(6):321-30. PubMed ID: 7855100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human lung cancers growing on extracellular matrix: expression of oncogenes and growth factors.
    Pavelic K; Antonic M; Pavelic L; Pavelic J; Pavelic Z; Spaventi S
    Anticancer Res; 1992; 12(6B):2191-6. PubMed ID: 1363516
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of cigarette smoking and asbestos exposure with location and histology of lung cancer.
    Lee BW; Wain JC; Kelsey KT; Wiencke JK; Christiani DC
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):748-55. PubMed ID: 9517586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Progress in oncogenes and anti-cancer genes in lung cancer].
    Guo X; Deng W; Huang S
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Oct; 18(5):267-9. PubMed ID: 8762477
    [No Abstract]   [Full Text] [Related]  

  • 46. Amplification of the N-myc oncogene in an adenocarcinoma of the lung.
    Saksela K; Bergh J; Nilsson K
    J Cell Biochem; 1986; 31(4):297-304. PubMed ID: 3020069
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oncogenes come of age.
    Varmus H; Pao W; Politi K; Podsypanina K; Du YC
    Cold Spring Harb Symp Quant Biol; 2005; 70():1-9. PubMed ID: 16869733
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EGFR gene deregulation mechanisms in lung adenocarcinoma: A molecular review.
    Tsiambas E; Lefas AY; Georgiannos SN; Ragos V; Fotiades PP; Grapsa D; Stamatelopoulos A; Kavantzas N; Patsouris E; Syrigos K
    Pathol Res Pract; 2016 Aug; 212(8):672-7. PubMed ID: 27461822
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aberrant hypermethylation at the bcl-2 locus at 18q21 in human lung cancers.
    Nagatake M; Osada H; Kondo M; Uchida K; Nishio M; Shimokata K; Takahashi T; Takahashi T
    Cancer Res; 1996 Apr; 56(8):1886-91. PubMed ID: 8620509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene expression profiling of cultured human bronchial epithelial and lung carcinoma cells.
    Hellmann GM; Fields WR; Doolittle DJ
    Toxicol Sci; 2001 May; 61(1):154-63. PubMed ID: 11294986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of Oncogenes and Tumor-suppressor Genes in Carcinogenesis: A Review.
    Kontomanolis EN; Koutras A; Syllaios A; Schizas D; Mastoraki A; Garmpis N; Diakosavvas M; Angelou K; Tsatsaris G; Pagkalos A; Ntounis T; Fasoulakis Z
    Anticancer Res; 2020 Nov; 40(11):6009-6015. PubMed ID: 33109539
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oncogenes and tumor-suppressor genes.
    Lehman TA; Reddel R; Peiifer AM; Spillare E; Kaighn ME; Weston A; Gerwin BI; Harris CC
    Environ Health Perspect; 1991 Jun; 93():133-44. PubMed ID: 1685442
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gene therapy for lung cancer: practice and promise.
    Vattemi E; Claudio PP
    Ann Ital Chir; 2004; 75(3):279-89. PubMed ID: 15605515
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activated protooncogenes in human lung tumors from smokers.
    Reynolds SH; Anna CK; Brown KC; Wiest JS; Beattie EJ; Pero RW; Iglehart JD; Anderson MW
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1085-9. PubMed ID: 1996309
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oncogenes in human lung cancer.
    Kratzke RA; Shimizu E; Kaye FJ
    Cancer Treat Res; 1992; 63():61-85. PubMed ID: 1363367
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic etiology of lung cancer.
    Otterson G; Lin A; Kay F
    Oncology (Williston Park); 1992 Sep; 6(9):97-104, 107; discussion 108, 111-2. PubMed ID: 1449981
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical implications of molecular abnormalities in lung cancer.
    Dziadziuszko R; Jassem E; Jassem J
    Cancer Treat Rev; 1998 Oct; 24(5):317-30. PubMed ID: 9861195
    [No Abstract]   [Full Text] [Related]  

  • 58. p53 and ras gene mutations in lung cancer: implications for smoking and occupational exposures.
    Husgafvel-Pursiainen K; Ridanpää M; Anttila S; Vainio H
    J Occup Environ Med; 1995 Jan; 37(1):69-76. PubMed ID: 7620945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas.
    Bonner AE; Lemon WJ; Devereux TR; Lubet RA; You M
    Oncogene; 2004 Feb; 23(5):1166-76. PubMed ID: 14647414
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cell cycle, tumor suppressor genes and lung cancers].
    Bréchot JM
    Rev Mal Respir; 1998 Sep; 15(4):461-6. PubMed ID: 9805756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.